Back to Search
AHMAD TARHINI, MD
MD
Hematology & Oncology Physician
NPI: 1811934755IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
MD424978(PA)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
OTHER
Class of 1999
Research & Publications (20)
A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma.
PMID 19140204·Cancer·2009
3-trial
Despite past disappointments, the future of melanoma therapy appears bright.
PMID 19544692·Oncology (Williston Park)·2009
8-other
Prognostic significance of serum S100B protein in high-risk surgically resected melanoma patients participating in Intergroup Trial ECOG 1694.
PMID 19047287·J Clin Oncol·2009
8-other
Tremelimumab (CP-675,206): a fully human anticytotoxic T lymphocyte-associated antigen 4 monoclonal antibody for treatment of patients with advanced cancers.
PMID 18774925·Expert Opin Biol Ther·2008
8-other
A phase 2 trial of sequential temozolomide chemotherapy followed by high-dose interleukin 2 immunotherapy for metastatic melanoma.
PMID 18720480·Cancer·2008
3-trial
Safety and efficacy of arsenic trioxide for patients with advanced metastatic melanoma.
PMID 18286511·Cancer·2008
3-trial
Tremelimumab, a fully human monoclonal IgG2 antibody against CTLA4 for the potential treatment of cancer.
PMID 17932815·Curr Opin Mol Ther·2007
6-review
Durable complete responses with high-dose bolus interleukin-2 in patients with metastatic melanoma who have experienced progression after biochemotherapy.
PMID 17761969·J Clin Oncol·2007
3-trial
Does childhood vaccination and exposure to infection improve long-term survival in patients with malignant melanoma?
PMID 16264957·Nat Clin Pract Oncol·2005
8-other
Novel agents in development for the treatment of melanoma.
PMID 16022577·Expert Opin Investig Drugs·2005
6-review
First International Symposium on Melanoma and Other Cutaneous Malignancies.
PMID 15335320·Expert Opin Biol Ther·2004
8-other
Effectiveness of wastewater management in rural areas of developing countries: a case of Al-Chouf Caza in Lebanon.
PMID 19184488·Environ Monit Assess·2010
8-other
Biomarkers of therapeutic response in melanoma and renal cell carcinoma: potential inroads to improved immunotherapy.
PMID 19364958·J Clin Oncol·2009
8-other
Does pegylated interferon alpha-2b confer additional benefit in the adjuvant treatment of high-risk melanoma?
PMID 19092800·Nat Clin Pract Oncol·2009
8-other
Chemoimmunotherapy with low-dose fludarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemia.
PMID 19075274·J Clin Oncol·2009
8-other
Decentralized approaches to wastewater treatment and management: applicability in developing countries.
PMID 18701206·J Environ Manage·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 LOTHROP ST, SUITE 9055 FORBES TOWER
PITTSBURGH, PA 15213 - Phone
- (412) 647-3087
Quick Facts
- NPI
- 1811934755
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 27
- Publications
- 20
Are you this provider?
Claim Your Profile